REGN
Regeneron Pharmaceuticals Inc
BIOTECHNOLOGY · HEALTHCARE
Regeneron Pharmaceuticals, Inc. is a prominent American biotechnology firm headquartered in Westchester County, New York, renowned for its pioneering work in monoclonal antibodies and therapeutic proteins. The company excels in various therapeutic areas, notably oncology, ophthalmology, and immunolo...
$779.67
-0.23% ($1.77)
Volume
615,295
52W High
$821.11
52W Low
$476.49
Market Cap
$60.54B
Next Earnings Report
Last Reported
Jan 30, 2026 Beat
Actual: $11.44
vs. Consensus: $10.77
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Jan 30, 2026
5-Day:
+4.53%
Q3 2025
Oct 30, 2025
1-Day:
-0.34%
5-Day:
-3.98%
Q2 2025
Aug 1, 2025
5-Day:
-0.67%
Q1 2025
Apr 29, 2025
1-Day:
+5.25%
Company Information
Symbol
REGN
Company
Regeneron Pharmaceuticals Inc
Market Cap
$60.54B
Sector
HEALTHCARE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in BIOTECHNOLOGY
Compare REGN with competitors
Side-by-side earnings comparison